MA
Mark M. Awad is a researcher at Dana-Farber Cancer Institute in the United States. His research focuses on lung cancer and immunotherapy, including targeted therapies and immune checkpoint inhibitors. He has contributed to clinical trials for thoracic malignancies.
- Field
- Medicine · Oncology
- Clarivate categories
- Clinical Medicine
- Affiliation
- Dana-Farber Cancer Institute, United States
- Secondary affiliation
- Harvard Medical School, United States